Efficacy and safety of tocilizumab in COVID-19 patients

In this retrospective study we assessed the efficacy and safety of tocilizumab in patients with critical or severe coronavirus disease 2019 (COVID-19). We enrolled 181 patients admitted to Huoshenshan Hospital (Wuhan, China) with confirmed COVID-19 between January 2020 and February 2020. Ninety-two...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Aging (Albany NY)
Hlavní autoři: Zheng, Kai-Lian, Xu, Ying, Guo, Yu-Feng, Diao, Le, Kong, Xiang-Yu, Wan, Xiao-Jian, Zhao, Feng, Ning, Fang-Zheng, Wang, Li-Bing, Qiao, Fan, Zhao, Jiang-Man, Zhou, Jia-Huan, Zhong, Yue-Qian, Wu, Shou-Xin, Chen, Yi, Jin, Gang, Dong, Yu-Chao
Médium: Artigo
Jazyk:Inglês
Vydáno: Impact Journals 2020
Témata:
Research Paper
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7732317/
https://ncbi.nlm.nih.gov/pubmed/33031060
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/aging.103988
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky